Late-onset sporadic Alzheimer's disease (AD) is a multifactorial disease in which several
risk factors contribute to the onset and disease progression. Risk factors for AD include …

Alzheimer's disease (AD) and stroke are two interrelated neurodegenerative disorders
which are the leading cause of death and affect the neurons in the brain and central nervous …

There is a huge need for novel therapeutic and preventative approaches to Alzheimer's
disease (AD) and neuroinflammation seems to be one of the most fascinating solutions. The …

Neuroinflammation has been implicated in the pathology of Alzheimer′ s disease (AD) for
decades. Still it has not been fully understood when and how inflammation arises in the …

Alzheimer's disease is an age-dependent neurodegenerative disorder characterized by loss
of neurons, synaptic degeneration, senile plaques and neurofibrillary tangles. Besides these …

Neuroinflammation represents a central feature in the development of Alzheimer's disease
(AD). The resident innate immune cells of the brain are the principal players in …

Background The blood-brain barrier (BBB) dysfunction represents an early feature of
Alzheimer's disease (AD) that precedes the hallmarks of amyloid beta (amyloid β) plaque …

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease with cognitive
decline and behavioral dysfunction. AD will become a global public health concern due to its …

Human and animal studies suggest that inflammation occurring outside the central nervous
system (systemic inflammation) may play a key role in promoting neurodegeneration …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the brain, which is
characterized by the formation of extracellular amyloid plaques (or senile plaques) and …